drugset / Trial / NCT03937505

A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy

NCT03937505 ↗

Phase 2 Completed 94 enrolled Intuitive Surgical
Non-randomizedSequentialOpen-labelPrevention

Summary

This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation. Stage A of the study will determine the safe optimal dose and Stage B will determine expanded safety and efficacy for intraoperative ureter structure delineation for the identified optimal dose in study participants.

Timeline

Start
2019-05-28
Primary completion
2021-07-08
Completion
2021-07-22

Drugs

EvaluationDrugModalityDoseRoute
Subject IS-001 Diagnostic / imaging agent 20 mg Intravenous

Indications